KR20250042844A - 결장 세정을 위한 조성물 및 위장 장애의 치료 - Google Patents

결장 세정을 위한 조성물 및 위장 장애의 치료 Download PDF

Info

Publication number
KR20250042844A
KR20250042844A KR1020257008457A KR20257008457A KR20250042844A KR 20250042844 A KR20250042844 A KR 20250042844A KR 1020257008457 A KR1020257008457 A KR 1020257008457A KR 20257008457 A KR20257008457 A KR 20257008457A KR 20250042844 A KR20250042844 A KR 20250042844A
Authority
KR
South Korea
Prior art keywords
cys
seq
glu leu
xaa
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257008457A
Other languages
English (en)
Korean (ko)
Inventor
마크 지. 커리
로버트 솔링가
크리스토퍼 라이티저
Original Assignee
아이언우드 파마슈티컬스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이언우드 파마슈티컬스, 인코포레이티드 filed Critical 아이언우드 파마슈티컬스, 인코포레이티드
Publication of KR20250042844A publication Critical patent/KR20250042844A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020257008457A 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료 Pending KR20250042844A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
US62/156,077 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders
KR1020177034808A KR102783759B1 (ko) 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177034808A Division KR102783759B1 (ko) 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료

Publications (1)

Publication Number Publication Date
KR20250042844A true KR20250042844A (ko) 2025-03-27

Family

ID=55953439

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020257008457A Pending KR20250042844A (ko) 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료
KR1020177034808A Active KR102783759B1 (ko) 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020177034808A Active KR102783759B1 (ko) 2015-05-01 2016-04-29 결장 세정을 위한 조성물 및 위장 장애의 치료

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP4218789A3 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR20250042844A (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA3172777A1 (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618938B2 (en) * 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders
SI3464336T1 (sl) 2016-06-01 2022-06-30 Athira Pharma, Inc. Spojine
CA3238634A1 (en) * 2021-11-24 2023-06-01 Christopher Leitheiser Synthetic process for production of modified gcc receptor agonists
WO2023097210A1 (en) * 2021-11-24 2023-06-01 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain
WO2026050206A1 (en) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
BR122018074353B8 (pt) * 2003-01-28 2023-05-02 Ironwood Pharmaceuticals Inc composição farmacêutica, polipeptídeo e métodos para a produção dos mesmos
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
EP1940441A4 (en) * 2005-08-19 2010-01-27 Ironwood Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
US20110172126A1 (en) * 2008-09-03 2011-07-14 Xenome Ltd Libraries of peptide conjugates and methods for making them
CA2790213A1 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
MX357121B (es) * 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) * 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
PL3004138T3 (pl) * 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
US10618938B2 (en) 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
MD3288578T2 (ro) 2023-08-31
RS64160B1 (sr) 2023-05-31
SMT202300114T1 (it) 2023-05-12
US10618938B2 (en) 2020-04-14
CY1126031T1 (el) 2023-11-15
JP7862355B2 (ja) 2026-05-19
CN114716514A (zh) 2022-07-08
FI3288578T3 (fi) 2023-05-03
EP3288578A1 (en) 2018-03-07
EP3288578B8 (en) 2023-03-29
US20180148476A1 (en) 2018-05-31
EP3288578B1 (en) 2023-03-15
JP2025169325A (ja) 2025-11-12
EP4218789A2 (en) 2023-08-02
MA41985B1 (fr) 2023-04-28
CA2984437A1 (en) 2016-11-10
EP4218789A3 (en) 2023-09-27
CN108040482B (zh) 2022-03-29
PT3288578T (pt) 2023-03-28
WO2016178979A1 (en) 2016-11-10
LT3288578T (lt) 2023-04-25
CA3172777A1 (en) 2016-11-10
ES2947591T3 (es) 2023-08-11
CA2984437C (en) 2025-11-18
JP2018519254A (ja) 2018-07-19
MX2022013283A (es) 2022-12-13
JP2024015335A (ja) 2024-02-01
JP2020203954A (ja) 2020-12-24
DK3288578T5 (da) 2024-10-07
SI3288578T1 (sl) 2023-07-31
KR20180005675A (ko) 2018-01-16
KR102783759B1 (ko) 2025-03-21
CN108040482A (zh) 2018-05-15
JP2022121734A (ja) 2022-08-19
DK3288578T3 (da) 2023-05-01
HUE061954T2 (hu) 2023-09-28
JP6930919B2 (ja) 2021-09-01
HRP20230381T1 (hr) 2023-07-07
PL3288578T3 (pl) 2023-08-14
EA201792401A1 (ru) 2018-05-31
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
US20240199697A1 (en) 2024-06-20
BR112017023539A2 (pt) 2018-08-14

Similar Documents

Publication Publication Date Title
JP7862355B2 (ja) 結腸洗浄及び胃腸障害の治療のための組成物
EP2509992B1 (en) Treatments for gastrointestinal disorders
CN102869677B (zh) 胃肠病症的治疗
CA2779482A1 (en) Treatments for gastrointestinal disorders
AU2014218599C1 (en) Guanylate cyclase receptor agonists for use in colonic cleansing
HK40097176A (en) Compositions for colon cleansing and the treatment of gastrointestnal disorders
HK40080323A (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
EA048992B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
EA053280B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
BR112017023539B1 (pt) Peptídeos ou sais farmaceuticamente aceitáveis do mesmo, seus métodos de produção, seus usos e composições farmaceuticas
HK1179637A (en) Treatment for gastrointestinal disorders
HK1179637B (en) Treatment for gastrointestinal disorders

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20250314

Application number text: 1020177034808

Filing date: 20171201

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250402

Comment text: Request for Examination of Application